Attending 5th Varian Oncology Summit 2019: Learning Experiences as a Medical Physicist

Authors

  • Venugopal Sudaram Senior Medical Physicist cum RSO Department of Radiation Oncology, Nepal Cancer Hospital and Research Center, Harisiddhi, Lalitpur, Nepal

Keywords:

IMRT, Medical Physicist, Radiation Oncologist, Varian, VMAT

Abstract

The main objective of the conference was to provide insights into new innovation and technology-related products by Varian to its global users, thus aiming to facilitate better and advance treatment to every cancer patients. Varian organized this summit to create a platform for its users to share their experience and knowledge not only in India but also the neighbouring country such as Nepal, Bangladesh, etc. The need for radiotherapy center in our country Nepal has been growing rapidly yet there are only a few radiotherapy centers with less or not enough needed technical resources and manpower (Radiation oncologists (ROs), Medical physicists (MPs), Radiotherapy Technologists (RTT’s)). Many radiotherapy centers still followed basic treatment modality only. However, due to the lack of high-end treatment techniques such as Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), Stereotactic Radio Surgery (SRS) and Stereotactic Radio Therapy (SRT) in Nepal, it poses a great burden to patients as they have to travel outside the country to get better quality treatment.

Downloads

Download data is not yet available.
Abstract
93
pdf
89

Downloads

Published

2019-12-31

How to Cite

Sudaram, V. (2019). Attending 5th Varian Oncology Summit 2019: Learning Experiences as a Medical Physicist. Europasian Journal of Medical Sciences, 1(1), 72–74. Retrieved from https://nepjol.info./index.php/ejms/article/view/35592

Issue

Vol. 1 No. 1 (2019): EJMS | July-December Issue

Section

Conference Reports

License

All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author(s) as the copyright holder will retain the ownership of the copyrights without any restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.

On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/